{"id":9203,"date":"2016-07-29T07:35:44","date_gmt":"2016-07-29T07:35:44","guid":{"rendered":"http:\/\/wames.org.uk\/cms-english\/?p=9203"},"modified":"2016-07-29T07:35:44","modified_gmt":"2016-07-29T07:35:44","slug":"variable-effects-of-clonidine-treatment-in-cfs","status":"publish","type":"post","link":"https:\/\/wames.org.uk\/cms-english\/variable-effects-of-clonidine-treatment-in-cfs\/","title":{"rendered":"Variable effects of clonidine treatment in CFS"},"content":{"rendered":"<h3>Research abstract:<\/h3>\n<p><a href=\"https:\/\/en.wikipedia.org\/wiki\/Clonidine\" target=\"_blank\">Clonidine<\/a>, an \u03b12-adrenergic receptor agonist, decreases circulating <a href=\"https:\/\/en.wikipedia.org\/wiki\/Norepinephrine\" target=\"_blank\">norepinephrin<\/a>e and <a href=\"https:\/\/en.wikipedia.org\/wiki\/Epinephrine\" target=\"_blank\">epinephrine<\/a>, attenuating <a href=\"https:\/\/www.sciencedaily.com\/terms\/sympathetic_nervous_system.htm\" target=\"_blank\">sympathetic activity<\/a>.<\/p>\n<p>Although <a href=\"https:\/\/en.wikipedia.org\/wiki\/Catechol-O-methyl_transferase\" target=\"_blank\">catechol-O-methyltransferase <\/a>(COMT) metabolizes catecholamines, main effectors of sympathetic function, COMT genetic variation effects on clonidine treatment are unknown. Chronic fatigue syndrome (CFS) is hypothesized to result in part from dysregulated sympathetic function.<\/p>\n<p>A candidate gene analysis of COMT rs4680 effects on clinical outcomes in the Norwegian Study of Chronic Fatigue Syndrome in Adolescents: Pathophysiology and Intervention Trial (NorCAPITAL), a randomized double-blinded clonidine versus placebo trial, was conducted (N=104).<\/p>\n<p>Patients homozygous for rs4680 high-activity allele randomized to clonidine took 2500 fewer steps compared with placebo (P_interaction=0.04). There were no differences between clonidine and placebo among patients with COMT low-activity alleles. Similar gene-drug interactions were observed for sleep (P_interaction=0.003) and quality of life (P_interaction=0.018).<\/p>\n<p>Detrimental effects of clonidine in the subset of CFS patients homozygous for COMT high-activity allele warrant investigation of potential clonidine-COMT interaction effects in other conditions.<\/p>\n<p><a href=\"http:\/\/www.nature.com\/tpj\/journal\/vaop\/ncurrent\/abs\/tpj201653a.html\" target=\"_blank\">Genetic variation in catechol-O-methyltransferase modifies effects of clonidine treatment in chronic fatigue syndrom<\/a>e, by KT Hall, J Kossowsky, TF Oberlander, TJ Kaptchuk, JP Saul, VB Wyller, E Fagermoen, D Sulheim, J Gjerstad, A Winger, KJ Mukama <span style=\"text-decoration: underline;\">in<\/span> the <em>Pharmacogenomics Journal<\/em> [online publication 26 July 2016]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Research abstract: Clonidine, an \u03b12-adrenergic receptor agonist, decreases circulating norepinephrine and epinephrine, attenuating sympathetic activity. Although catechol-O-methyltransferase (COMT) metabolizes catecholamines, main effectors of sympathetic function, COMT genetic variation effects on clonidine treatment are unknown. Chronic fatigue syndrome (CFS) is hypothesized &hellip; <a href=\"https:\/\/wames.org.uk\/cms-english\/variable-effects-of-clonidine-treatment-in-cfs\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[2958,208,2011,2959],"class_list":["post-9203","post","type-post","status-publish","format-standard","hentry","category-news","tag-catechol-o-methyltransferase","tag-clonidine","tag-comt","tag-kt-hall"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p5qkYK-2or","_links":{"self":[{"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/posts\/9203","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/comments?post=9203"}],"version-history":[{"count":1,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/posts\/9203\/revisions"}],"predecessor-version":[{"id":9204,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/posts\/9203\/revisions\/9204"}],"wp:attachment":[{"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/media?parent=9203"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/categories?post=9203"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/tags?post=9203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}